Cargando…
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals
BACKGROUND: The development of radiopharmaceuticals requires extensive evaluation before they can be applied in a diagnostic or therapeutic setting in Nuclear Medicine. Chemical, radiochemical, and pharmaceutical parameters must be established and verified to ensure the quality of these novel produc...
Autores principales: | Korde, Aruna, Mikolajczak, Renata, Kolenc, Petra, Bouziotis, Penelope, Westin, Hadis, Lauritzen, Mette, Koole, Michel, Herth, Matthias Manfred, Bardiès, Manuel, Martins, Andre F., Paulo, Antonio, Lyashchenko, Serge K., Todde, Sergio, Nag, Sangram, Lamprou, Efthimis, Abrunhosa, Antero, Giammarile, Francesco, Decristoforo, Clemens |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9296747/ https://www.ncbi.nlm.nih.gov/pubmed/35852679 http://dx.doi.org/10.1186/s41181-022-00168-x |
Ejemplares similares
-
Clinical translation of theranostic radiopharmaceuticals: Current regulatory status and recent examples
por: Kolenc Peitl, Petra, et al.
Publicado: (2019) -
Position paper on requirements for
toxicological studies in the specific case of radiopharmaceuticals
por: Koziorowski, J., et al.
Publicado: (2016) -
EANM guideline on the validation of analytical methods for radiopharmaceuticals
por: Gillings, Nic, et al.
Publicado: (2020) -
Update on Preclinical Development and Clinical Translation of Cholecystokinin-2 Receptor Targeting Radiopharmaceuticals
por: von Guggenberg, Elisabeth, et al.
Publicado: (2021) -
EANM guideline on quality risk management for radiopharmaceuticals
por: Gillings, Nic, et al.
Publicado: (2022)